25 researchers from Health at Aarhus University have received a grant from the Independent Research Fund Denmark, Thematic research – Strengthened clinical and independent research. Six of the researchers are from DCE:

Professor Alma Becic Pedersen receives DKK 3,075,408 for the project "Osteoporotic hip fracture and mental illness: treatment, prognosis, and costs." The researcher analyzes disparities in treatment and complications among hip fracture patients with mental illness, with a focus on osteoporosis and rehabilitation.

Professor Christian Fynbo Christiansen receives DKK 3,161,808 for the project “Targeted referral and care of chronic kidney disease - the right care to the right patients.” This project explores whether a risk model can improve the referral of patients with chronic kidney disease from general practice to specialists, as well as the economic consequences of using the model.

Professor Lars Pedersen receives DKK 1,839,600 for the project "Improving Colorectal Cancer Research Using Target Trial Emulation." This project aims to develop algorithms to analyze observational health data to improve research and clinical decision-making, especially in colorectal cancer.

Clinical Professor Peter Jepsen receives DKK 3,147,273 for the project "Introducing surveillance for hepatocellular carcinoma in the Central Denmark Region." The researcher examines the effect of liver cancer screening in patients with cirrhosis in the Central Denmark Region to reduce mortality.

Associate Professor Anne Sofie Dam Laursen receives DKK 3,166,416 for the project “Endocrine disrupting chemicals and spontaneous abortion: Do time of exposure and folate intake matter?” This project investigates the relationship between endocrine-disrupting chemicals and the risk of spontaneous abortion by analyzing blood and urine samples from women before and early in pregnancy. It also examines whether folic acid intake can mitigate the harmful effects of these chemicals.

PhD Irene Petersen receives DKK 2,995,920 for the project "Association between initiation of statin treatment and diabetes." This study examines the relationship between statin treatment and diabetes risk by analyzing changes in blood sugar (HbA1c) in Danish patients to weigh the benefits of statins against the risk of diabetes.

The full list of grant recipients at Health can be viewed here